7 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of EO2002 in Subjects With Corneal Edema Secondary to Corneal Endothelial DysfunctionChandler syndrome, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Corneal Endothelial Cell Loss, Corneal Endothelial Dystrophy 1, Eye Diseases, Hereditary, Eye Manifestations, Fuchs' endothelial dystrophy, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Signs and Symptoms, congenital hereditary endothelial dystrophy of cornea, corneal disorder, corneal dystrophy, corneal edema, eye disorder, hereditary diseaseRecruitingPhase 22026-10-09NCT07729137
Long-term Follow-up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA)central nervous system disorder, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, spinal cord disorder, spinal muscular atrophyActive, not recruitingPhase 42026-09-09NCT05232929
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiencycorneal disorder, eye disorder, limbal stem cell deficiencyRecruitingPhase 12026-08-13NCT06452316
Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiencycorneal disorder, eye disorder, limbal stem cell deficiencyRecruitingNot stated2026-08-06NCT07636590
An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye DiseaseConjunctival Diseases, dry eye syndrome, eye disorder, lacrimal apparatus disorder, xerophthalmiaRecruitingPhase 22026-06-26NCT07503886
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal ScarsCorneal Injuries, Corneal Scar, Craniocerebral Trauma, Eye Injuries, Facial Injuries, corneal disorder, eye disorder, injury, nervous system disorder, nervous system injuryRecruitingPhase 12026-04-07NCT06257355
A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitisneurotrophic keratopathyRecruitingPhase 1 / Phase 22026-02-27NCT06999733